CGTX logo

CGTX
Cognition Therapeutics Inc

3,975
Mkt Cap
$80.83M
Volume
555,017.00
52W High
$3.83
52W Low
$0.2223
PE Ratio
-2.63
CGTX Fundamentals
Price
$0.9046
Prev Close
$0.8602
Open
$0.909
50D MA
$1.03
Beta
1.77
Avg. Volume
1.3M
EPS (Annual)
-$0.3228
P/B
2.35
Rev/Employee
$0.00
$61.87
Loading...
Loading...
News
all
press releases
Q1 Earnings Forecast for CGTX Issued By HC Wainwright
Cognition Therapeutics, Inc. (NASDAQ:CGTX - Free Report) - HC Wainwright issued their Q1 2027 earnings per share (EPS) estimates for Cognition Therapeutics in a research report issued on Friday...
MarketBeat·13d ago
News Placeholder
More News
News Placeholder
Cognition Therapeutics, Inc. (NASDAQ:CGTX) Given Average Rating of "Moderate Buy" by Brokerages
Cognition Therapeutics, Inc. (NASDAQ:CGTX - Get Free Report) has been assigned an average rating of "Moderate Buy" from the four research firms that are covering the stock, MarketBeat reports. One...
MarketBeat·16d ago
News Placeholder
Cognition Therapeutics (NASDAQ:CGTX) Receives Buy Rating from Chardan Capital
Chardan Capital restated a "buy" rating and set a $4.00 target price on shares of Cognition Therapeutics in a research report on Friday...
MarketBeat·16d ago
News Placeholder
Cognition Therapeutics Q4 Earnings Call Highlights
Cognition Therapeutics (NASDAQ:CGTX) used its fourth-quarter and full-year 2025 earnings call to outline a shift in development priorities for its lead candidate, zervimesine (CT-1812), with management saying it will now focus on pursuing a registration path in dementia with Lewy bodies (DLB) psycho...
MarketBeat·17d ago
News Placeholder
Cognition Therapeutics (NASDAQ:CGTX) Posts Earnings Results, Beats Estimates By $0.04 EPS
Cognition Therapeutics (NASDAQ:CGTX - Get Free Report) posted its earnings results on Thursday. The company reported ($0.02) EPS for the quarter, topping analysts' consensus estimates of ($0.06) by $0.04...
MarketBeat·17d ago
News Placeholder
Cognition Therapeutics (CGTX) Projected to Post Quarterly Earnings on Wednesday
Cognition Therapeutics (NASDAQ:CGTX) will be releasing its Q4 2025 earnings before the market opens on Wednesday, April 1. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-4-1-cognition-therapeutics-inc-stock...
MarketBeat·18d ago
News Placeholder
Cognition Therapeutics, Inc. (NASDAQ:CGTX) Receives Consensus Rating of "Moderate Buy" from Analysts
Shares of Cognition Therapeutics, Inc. (NASDAQ:CGTX - Get Free Report) have been assigned a consensus recommendation of "Moderate Buy" from the five brokerages that are currently covering the...
MarketBeat·1mo ago
News Placeholder
FY2025 Earnings Forecast for CGTX Issued By Brookline Cap M
Cognition Therapeutics, Inc. (NASDAQ:CGTX - Free Report) - Investment analysts at Brookline Cap M issued their FY2025 EPS estimates for Cognition Therapeutics in a research note issued to investors...
MarketBeat·2mo ago
News Placeholder
Cognition Therapeutics (NASDAQ:CGTX) Upgraded to Strong-Buy at Brookline Cap M
Brookline Cap M raised shares of Cognition Therapeutics to a "strong-buy" rating in a research report on Tuesday...
MarketBeat·2mo ago
News Placeholder
Brookline Capital Management Predicts CGTX FY2025 Earnings
Cognition Therapeutics, Inc. (NASDAQ:CGTX - Free Report) - Brookline Capital Management issued their FY2025 earnings estimates for shares of Cognition Therapeutics in a research report issued on...
MarketBeat·2mo ago
<
1
2
...
>

Latest CGTX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.